期刊文献+

3D肝细胞模型研究大黄素型单蒽酮肝细胞毒性 被引量:8

Study the hepatotoxicity of monoanthranone with emodin-type using in vitro 3D liver model
原文传递
导出
摘要 目的:首次研究何首乌中大黄素型单蒽酮的潜在肝细胞毒性及其作用机制。方法:本研究利用悬滴技术构建以人肝细胞HepaRG和人星型细胞HSC为基础的3D多细胞聚球体模型,用该模型评价何首乌中大黄素型单蒽酮成分的重复给药毒性,并与2D模型下单次给药毒性进行比较。进一步研究大黄素型单蒽酮对主要肝药酶和外排转运体表达的影响。结果:肝脏3D多细胞聚球体模型体外培养15 d仍然可以维持较好的肝脏功能。大黄素型单蒽酮2D培养给药48 h,IC50为1. 091μg·mL-1。肝脏3D悬滴模型下连续给药6 d,同浓度大黄素型单蒽酮对肝细胞毒性显著性小于2D培养评价结果。RT-PCR结果显示大黄素型单蒽酮体外多次给药上调主要肝药酶CYP3A4,CYP2B6及外排转运体P-糖蛋白和多药耐药转运蛋白2(MRP2)。结论:何首乌中的新化合物大黄素型单蒽酮具有明显的肝细胞毒性,体外3D模型多次给药引起主要肝药酶和外排转运体表达上调,为肝细胞降低大黄素型单蒽酮毒性提供了潜在机制,同时也提示服用含有大黄素型单蒽酮化合物的中药可能会产生药物相互作用。 Objective:To study the hepatotoxicity of monanthone with emodin type in Polygonummultiflorum and its potential mechanisms for the first time.Methods:We used the hanging drop technique to construct a 3D multicellular polysphere model based on human hepatocyte HepaRG and human stellate cells HSC.The model was used to evaluate the repeated administration toxicity of monanthone with emodin type in Polygonummultiflorum and compared with the toxicity of single administration in 2D model.The effects of monoanthrone with emodin type on the expression of major hepatic enzymes and efflux transporters were further studied.Results:3D multicellular polysphere model still can maintain preferable hepatic function after in vitro culture for 15 d.The IC50 of monanthonewith emodin type in the 2D model was 1.091μg·mL-1 after culture for 48 h.In the hanging drop 3D model,cytotoxicity was significantly lower than 2D results after 6 d repeated administration.RT-PCR results showed that CYP3 A4,CYP2 B6,P-gp and MRP RNA expressions were significantly increased after in vitro multiple-dose of monanthone with emodin type.Conclusion:The monanthone with emodin type in Polygonummultiflorum has obvious hepatotoxicity.Multiple-dose in vitro in 3D model of the monanthone with emodin type increases the major CYP enzymes and efflux transporters,provides a potential mechanism for reducing the toxicity of emodin-type monoanthrone by hepatocytes.The results also demonstrated that monanthone with emodin type may potentially induce drug-drug interactions.
作者 淡墨 刘栋 黄舒佳 王宇 汪祺 赵燕燕 DAN Mo;LIU Dong;HUANG Shu-jia;WANG Yu;WANG Qi;ZHAO Yan-yan(School of Pharmaceutical,Hebei University,Baoding 071002,China;National Center for Safety Evaluation of Drugs,National Institute for Food and Drug Control,Key Laboratory of Beijing for Nonclinical Safety Evaluation Research of Drugs,Beijing 100176,China;Institute for Control of Chinese Traditional Medicine and Ethnic Medicine,National Institute for Food and Drug Control,Beijing 100050,China)
出处 《中国新药杂志》 CAS CSCD 北大核心 2019年第11期1312-1317,共6页 Chinese Journal of New Drugs
基金 国家“重大新药创制”科技重大专项资助项目(2018ZX09201017-001,2015ZX09501007-004) 国家自然基金资助项目(81503347,81401517)
关键词 何首乌 大黄素型单蒽酮 药物肝毒性 肝脏3D模型 Polygonummultiflorum Thunb. monanthone with emodin type drugs hepatotoxicity 3D liver model
  • 相关文献

参考文献3

二级参考文献31

  • 1Wang A,Yu BN,Luo CH,et al.Ile 118 Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients[J].Eur J Clin Pharmacol,2005,60(12):843-848.
  • 2Yamada Y,Matsuo H,Watanabe S,et al.Association of a polymorphism of CYP3A4 with type 2 diabetes mellitus[J].Int J Mol Med,2007,20(5):703-707.
  • 3Fukushima-Uesaka H,Saito Y,Watanabe H,et al.Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population[J].Human Mutation,2004,23(1):100.
  • 4Jing Du,Qinghe Xing,Lingyun Xu,et al.Systematic screening for polymorphisms in the CYP3A4 gene in the Chinese population[J].Pharmacogenomics,2006,7(6):831-841.
  • 5Hu YF,He J,Chen GL,et al.CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population[J].Clin Chim Acta,2005,353(1-2):187-192.
  • 6Ming-Hsien Tsai,Keh-Ming Lin,Mei-Chun Hsiao,et al.Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response[J].Pharmacogenomics,2010,11(4):537-546.
  • 7Su-Jun Lee,Sang Seop Lee,Hye-Eun Jeong,et al.The CYP3A4*18 allele,the most frequent coding variant in asian populations,does not significantly affect the midazolam disposition in heterozygous individuals[J].Drug Metab Dispos,2007,35(11):2095-2101.
  • 8Jun KR,Lee W,Jang MS,et al.Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea[J].Transplantation,2009,87(8):1225-1231.
  • 9Ruzilawati AB,Gan SH.CYP3A4 Genetic Polymorphism Influences Repaglinide's Pharmacokinetics[J].Pharmacology,2010,85(6):357-364.
  • 10Du J,Yu L,Wang L,et al.Differences in CYP3A41G genotype distribution and haplotypes of CYP3A4,CYP3A5 and CYP3A7 in 3 Chinese populations[J].Clin Chim Acta,2007,383:172-174.

共引文献32

同被引文献62

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部